Fred Schwarzer - 15 Mar 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
15 Mar 2022
Net transactions value
$0
Form type
4
Filing time
17 Mar 2022, 18:41:20 UTC
Previous filing
15 Mar 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +23,002 +193% $0.000000 34,935 15 Mar 2022 Direct F1
holding IGMS Common Stock 196,718 15 Mar 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2022, provided that the Reporting Person remains a service provider through the vesting date.
F2 The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.